A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin 1 predicts survival in patients with advanced gastric cancer
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.2, pp.399-406, 2017 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 47 Issue: 2
- Publication Date: 2017
- Doi Number: 10.3906/sag-1509-80
- Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.399-406
- Keywords: Docetaxel, cisplatin, 5-fluorouracil, VEGFA, angiopoietin 1, placental growth factor, angiogenesis prognostic index, gastric cancer, ENDOTHELIAL-GROWTH-FACTOR, GASTROESOPHAGEAL JUNCTION, HEPATOCELLULAR-CARCINOMA, VASCULAR MORPHOGENESIS, COLORECTAL-CANCER, CHEMOTHERAPY, EXPRESSION, CISPLATIN, THERAPY, METAANALYSIS
- Gazi University Affiliated: No
Abstract
Background/aim: The role of angiogenic factors in gastric cancer is not clear. We aimed to assess the role of vascular endothelial growth factor A (VEGFA), angiopoietin 1 (Ang-1), and placental growth factor (PlGF) in the prognosis of patients with advanced gastric cancer.